• Fri, March 18, 2022
• Sun, March 20, 2022
• Mon, March 21, 2022
David Westenberg Maintained (AKYA) at Buy with Decreased Target to $18 on, Mar 18th, 2022
David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $23 to $18 on, Mar 18th, 2022.
David has made no other calls on AKYA in the last 4 months.
There is 1 other peer that has a rating on AKYA. Out of the 1 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $19 on, Tuesday, March 15th, 2022
Like: 👍
